pravastatin has been researched along with Amyloid Deposits in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Anantharamaiah, GM; Cao, D; Garber, DW; Handattu, SP; Kadish, I; Li, L; Monroe, CE; Nayyar, G; Palgunachari, MN; van Groen, T | 1 |
1 other study(ies) available for pravastatin and Amyloid Deposits
Article | Year |
---|---|
Oral apolipoprotein A-I mimetic peptide improves cognitive function and reduces amyloid burden in a mouse model of Alzheimer's disease.
Topics: Administration, Oral; Alzheimer Disease; Amyloid beta-Peptides; Amyloid beta-Protein Precursor; Animals; Anticholesteremic Agents; Apolipoprotein A-I; Astrocytes; Chemokine CCL2; Cholesterol; Cognition; Disease Models, Animal; Drug Therapy, Combination; Hippocampus; Interleukin-1beta; Male; Maze Learning; Mice; Mice, Transgenic; Microglia; Plaque, Amyloid; Pravastatin; Protease Nexins; Receptors, Cell Surface; Tumor Necrosis Factor-alpha | 2009 |